Company Profiles

driven by the PitchBook Platform

Allakos

Description

Developer of antibody-based therapeutics intended to treat allergic and inflammatory diseases.The company's antibody-based therapeutics utilizes a pipeline of antibodies that target cell types implicated in allergic and inflammatory responses.

2012

Founded

PRIVATE

Status

11-50

Employees

Series A

Latest Deal Type

$42M

Latest Deal Amount

$42M

Total Amount Raised

Description

Developer of antibody-based therapeutics intended to treat allergic and inflammatory diseases.The company's antibody-based therapeutics utilizes a pipeline of antibodies that target cell types implicated in allergic and inflammatory responses.

Website:

www.allakos.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery
Drug Delivery

Primary Office

75 Shoreway Road San Carlos, CA 94070United States +1 (650) 597-5002
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Allakos's full profile, request a free trial.

    Allakos Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Allakos Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Allakos Investors (7)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Alta PartnersVenture CapitalMinority000 0000000 0000
    De Novo VenturesVenture CapitalMinority000 0000000 0000
    InterWest Healthcare PartnersVenture CapitalMinority000 0000000 0000
    NovoCorporate Venture CapitalMinority000 0000000 0000
    RiverVest Venture PartnersVenture CapitalMinority000 0000000 0000
    Alta Partners Venture Capital
    De Novo Ventures Venture Capital
    InterWest Healthcare Partners Venture Capital
    Novo Corporate Venture Capital
    RiverVest Venture Partners Venture Capital

    Allakos Executive Team (6)

    NameTitleBoard
    Seat
    Contact
    Info
    Christopher Bebbington Ph.DCo-Founder, Board Member, President & Chief Executive Officer
    Simon Greenwood Ph.DChief Business Officer
    Omer SiddiquiVice President, Clinical Operations
    Sally Bolmer Ph.DVice President, Regulatory Affairs and Drug Development
    Nenad Tomasevic Ph.DVice President, Research
    Christopher Bebbington Ph.D Co-Founder, Board Member, President & Chief Executive Officer
    Simon Greenwood Ph.D Chief Business Officer
    Omer Siddiqui Vice President, Clinical Operations
    Sally Bolmer Ph.D Vice President, Regulatory Affairs and Drug Development
    Nenad Tomasevic Ph.D Vice President, Research

    Allakos Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Carole Nuechterlein JDRoche Venture FundHead000 0000
    Farah ChampsiAlta PartnersManaging Director000 0000
    John McKearn Ph.DRiverVest Venture PartnersManaging Director000 0000
    Peter Moldt Ph.DNovoPartner, Novo Ventures000 0000
    Steven JamesSelfBoard Member000 0000
    Carole Nuechterlein JD Head Roche Venture Fund
    Farah Champsi Managing Director Alta Partners
    John McKearn Ph.D Managing Director RiverVest Venture Partners
    Peter Moldt Ph.D Partner, Novo Ventures Novo
    Steven James Board Member Self
    Request full access to PitchBook